Lenvatinib 4mg Lentris 4mg Capsule
Thyroid cancer
| Product | Lenvatinib 4mg Lentris 4mg Capsule |
|---|---|
| Used for | Thyroid cancer |
| Dosage form | Capsule |
| Pack | Standard manufacturer pack |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Composition | Lenvatinib |
| Strength | 4mg |
| Pack size | 10 capsules in 1 strip |
| Shelf life | 2 years |
| Storage | Store below 30°C, away from light and moisture. |
| Country of origin | India |
No payment is taken on this site. We reply with price, batch, expiry and shipping cost. Ask about this product on WhatsApp
Lenvatinib 4mg Lentris 4mg Capsule is a capsule in our Oncology range, used for thyroid cancer.
Lenvatinib 4mg Capsule is an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer. Lenvatinib 4mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Hormonal therapy, kinase inhibitors and CDK4/6 inhibitors for breast, prostate, lung, kidney and brain cancers.
This is a prescription medicine and must be used under the supervision of a registered medical practitioner.
